Novo Nordisk (NVO.US) sees weight-loss drug sales surge 40% in April after price cuts in India
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to market research firm Pharmarack, sales of Wegovy, Ozempic, and their partner brand versions reached 32,000 units in April, marking the first full month of data since generic semaglutide was launched in India. Starting from April 1, Novo Nordisk lowered the starting dose prices of both drugs by 36% and 48% respectively, bringing the price down to 5,660 rupees (approximately 60 US dollars).
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Broadcom Inc. Founder Cashes Out $250 Million in Company Stock
BlockBeats•2026/06/30 07:29
Trending news
MoreAccording to Japan's Asahi Shimbun, the general outline of the first annual core economic policy blueprint under the Kishida Sanae administration, titled "Basic Policy on Economic and Fiscal Management and Reform," has basically taken shape.
Broadcom Inc. Founder Cashes Out $250 Million in Company Stock
Crypto prices
More
Bitcoin
BTC
$59,397.77
-0.93%
Ethereum
ETH
$1,590.16
+0.65%
Tether USDt
USDT
$0.9985
-0.00%
USDC
USDC
$0.9997
-0.00%
XRP
XRP
$1.05
-0.20%
Solana
SOL
$73.83
+2.11%
TRON
TRX
$0.3191
-1.14%
Hyperliquid
HYPE
$65.48
+4.56%
Dogecoin
DOGE
$0.07227
-1.09%
Zcash
ZEC
$398.79
+3.95%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now